p53 logo

p53

Europe, Rogaland, Norway, Stavanger

Description

p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.

Investor Profile

p53 has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Norway, Denmark.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Life Science.

Stage Focus

  • Series A (100%)

Country Focus

  • Norway (50%)
  • Denmark (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does p53 frequently co-invest with?

Innovestor
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Sarsia
Europe, Hordaland, Norway, Bergen
Co-Investments: 1
Sound Bioventures
Europe, Skane Lan, Sweden, Malmö
Co-Investments: 1
Investinor
Europe, Sor-Trondelag, Norway, Trondheim
Co-Investments: 1
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1

What are some of recent deals done by p53?

Calluna Pharma

Oslo, Oslo, Norway

Calluna Pharma is developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.

BiotechnologyPharmaceutical
Series AJan 23, 2024
Amount Raised: $81,431,633
Teitur Trophics

Aarhus, Midtjylland, Denmark

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

BiotechnologyLife ScienceMedical
Series AMar 14, 2023
Amount Raised: $30,034,765